Fernando Rodrigues Goulart Bergamini

Professor at Institute of Chemistry, Federal University of Uberlândia, MG, Brazil. Bacharel in Chemistry (2006-2010, Institute of Chemistry, University of Campinas - UNICAMP, Campinas, Brazil), Master in Inorganic Chemistry (2011-2013, Institute of Chemistry, University of Campinas - UNICAMP, Campinas, Brazil), Doctor of Sciences (2013-2017, Institute of Chemistry, University of Campinas - UNICAMP, Campinas, Brazil). Pos-doc at Max-Planck Institute for Polymer Research (2021 - Currently; Mainz, Rheinland-Pfalz, Alemanha). Experience in Chemistry, with emphasis in coordination Chemistry, bioinorganic chemistry and biomedicine. The major interests rely on inorganic and physical chemistry applied in medicine. Currently his research is focused on the development of solutions for medical issues. In order to achieve such ambitious goal, it is aimed to develop new oligomeric macromolecules and materials encompassing metal ions [e.g. Cu(II), Ag(I), Au(I), Au(III), Pt(II), Pt(IV) and Pd(II)], well-stablished drugs, synthetic ligands as well as macromolecules such as peptides, proteins, lipids and carbohydrates as building blocks. The comprehension of how the associations of such building blocks into well-defined nanostructures/materials affect the biological outcome of the resultant compounds are the core of his research. For more information: http://bergaminilab.info/ Keywords: Drug Delivery; Protein; Nanostructure; Oligomer; Coordination chemistry; Medicinal Chemistry; Antimicrobial; antitumoral; metallodrugs; metal-directed protein self-assembly.

Professor at Institute of Chemistry, Federal University of Uberlândia, MG, Brazil. Bacharel in Chemistry (2006-2010, Institute of Chemistry, University of Campinas - UNICAMP, Campinas, Brazil), Master in Inorganic Chemistry (2011-2013, Institute of Chemistry, University of Campinas - UNICAMP, Campinas, Brazil), Doctor of Sciences (2013-2017, Institute of Chemistry, University of Campinas - UNICAMP, Campinas, Brazil). Pos-doc at Max-Planck Institute for Polymer Research (2021 - Currently; Mainz, Rheinland-Pfalz, Alemanha). Experience in Chemistry, with emphasis in coordination Chemistry, bioinorganic chemistry and biomedicine. The major interests rely on inorganic and physical chemistry applied in medicine. Currently his research is focused on the development of solutions for medical issues. In order to achieve such ambitious goal, it is aimed to develop new oligomeric macromolecules and materials encompassing metal ions [e.g. Cu(II), Ag(I), Au(I), Au(III), Pt(II), Pt(IV) and Pd(II)], well-stablished drugs, synthetic ligands as well as macromolecules such as peptides, proteins, lipids and carbohydrates as building blocks. The comprehension of how the associations of such building blocks into well-defined nanostructures/materials affect the biological outcome of the resultant compounds are the core of his research. For more information: http://bergaminilab.info/ Keywords: Drug Delivery; Protein; Nanostructure; Oligomer; Coordination chemistry; Medicinal Chemistry; Antimicrobial; antitumoral; metallodrugs; metal-directed protein self-assembly. Professor no Departamento de Química Inorgânica, Instituto de Química, Universidade Federal de Uberlândia, MG, Brasil. Bacharel em Química (2006-2010, Instituto de Química, Universidade Estadual de Campinas, UNICAMP, Campinas, SP, Brasil), Mestre em Química Inorgânica (2011-2013, Instituto de Química, Universidade Estadual de Campinas, UNICAMP, Campinas, SP, Brasil), Doutor em Ciências (2013-2017, Instituto de Química, Universidade Estadual de Campinas, UNICAMP, Campinas, SP, Brasil) . Estágio de Pós-doutorado no Max-Planck Institute for Polymer Research (2021 - atual; Mainz, Rheinland-Pfalz, Alemanha). Experiência na área de Química, com ênfase em química de Coordenação bio-inorgânica e biomedicina. Atualmente, sua linha de pesquisa envolve o desenvolvimento de solutions para problemas médicos. De modo a atingir este objetivo geral ambicioso, sua pesquisa compreende o desenvolvimento de macromoléculas e materiais envolvendo íons metálicos [por ex.Cu(II), Ag(I), Au(I), Au(III), Pt(II), Pt(IV) and Pd(II)], fármacos comerciais, ligantes sintéticos como também macromoléculas (peptídeos, proteinas, lipídeos e carboidratos) como blocos de montagem. O entendimento de como a associação destes blocos de montagem em nanoestruturas/materiais bem definidos afeta o resultado biologico dos compostos resultantes é o ponto central de suas pesquisas.